The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.
For nearly a century, surgical excision and Mohs surgery have been the gold standard for treating patients who have non-melanoma skin cancer (NMSC) and keloid disease. The surgery works extremely well – with cure rates…
Jeff Goldstein is a double lung transplant recipient and a multiple skin cancer survivor. Transplant recipients are immune compromised and has a pre-disposition to skin cancer. As a Floridian, Jeff spent a lot of time…
Daniel J. Ladd, Jr., DO is the Medical Director and Founder of Tru-Skin Dermatology in Austin, Texas and the 2018 President-Elect of the AOCD. He earned his BA from the University of Texas at Austin…
When patients are diagnosed with non-melanoma skin cancers like basal cell carcinoma and squamous cell carcinoma, the first questions they ask are typically along the lines of… What does this mean? How serious is this?…
For decades, Mohs surgery has been considered the “gold standard” for the treatment of basal cell carcinomas and squamous cell carcinomas, even for cases where cosmetically important features of the face like the eyes, nose,…
